BMA
CL icon

Brooks Moore & Associates’s Colgate-Palmolive CL Stock Holding History

Brooks Moore & Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,200
Closed -$279K – 86
2020
Q1 		$279K Hold
4,200
– – 0.3% 74
2019
Q4 		$289K Hold
4,200
– – 0.23% 88
2019
Q3 		$309K Hold
4,200
– – 0.26% 80
2019
Q2 		$301K Buy
+4,200
New +$298K 0.26% 83

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Brooks Moore & Associates's CL Position: Q2 2020 in Review

Brooks Moore & Associates sold out of Colgate-Palmolive (CL) in Q2 2020, closing a stake of 4,200 shares — an estimated $279K sold.

Brooks Moore & Associates first reported a position in CL in Q2 2019 and held it in 4 quarters. The position peaked at $309K in Q3 2019. 1,516 funds tracked by Wall St. Rank hold CL as of Q2 2020.

  • Brooks Moore & Associates reported no remaining Colgate-Palmolive position as of Q2 2020 after selling out during the quarter.
  • Brooks Moore & Associates sold 4,200 Colgate-Palmolive shares in Q2 2020, an estimated $279K.
  • Brooks Moore & Associates first reported a position in Colgate-Palmolive in Q2 2019 and held it in 4 quarters.
  • Brooks Moore & Associates's Colgate-Palmolive position peaked at $309K in Q3 2019.
  • 1,516 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2020.

Based on Brooks Moore & Associates's 13F filing for Q2 2020, filed 10 Aug 2020.